Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease

Atherosclerosis

Volumn 167, Issue 2, 2003, Pages 205-214

  Weisberg, Ilan S ^a   Park, Eric ^b   Ballman, Karla V ^c   Berger, Peter ^c   Nunn, Martha ^d   Suh, Daniel S ^a   Breksa III, Andrew P ^b   Garrow, Timothy A ^b   Rozen, Rima ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Betaine; Betaine homocysteine methyltransferase; Cardiovascular disease; Genetic variants; Homocysteine

Indexed keywords

BETAINE HOMOCYSTEINE METHYLTRANSFERASE; FOLIC ACID; ISOENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME ACTIVITY; EXON; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; STENOSIS;

EID: 0038124366     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00010-8     Document Type: Article

References (31)

1. Boushey C., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J. Am. Med. Assoc. 274:1995;1049-1057.
2. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Ann. Rev. Med. 49:1998;31-62.
3. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A.J., van den Heuvel L.P., Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
4. Weisberg I.S., Jacques P.F., Selhub J., Bostom A.G., Chen Z., Ellison R.C., Eckfeldt J.H., Rozen R. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis. 156:2001;409-415.
5. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 893:1996;7-9.
6. Morita H., Kurihara H., Tsubaki S., Sugiyama T., Hamada C., Kurihara Y., Shindo T., Oh-hashi Y., Kitamura K., Yazaki Y. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler. Thromb. Vasc. Biol. 18:1998;1465-1469.
7. Mager A., Lalezari S., Shohat T., Birnbaum Y., Adler Y., Magal N., Shohat M. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation. 100:1999;2406-2410.
8. Margaglione M., D'Andrea G., d'Addedda M., Giuliani N., Cappucci G., Iannaccone L., Veccione G., Grandone E., Brancaccio V., Di Minno G. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb. Haemost. 79:1998;907-911.
9. Shields D.C., Kirke P.N., Mills J.L., Ramsbottom D., Molloy A.M., Burke H., Weir D.G., Scott J.M., Whitehead A.S. The 'Thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet. 64:1999;1045-1055.
10. Botto L.D., Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a huge review. Am. J. Epidemiol. 9:2000;862-877.
11. Ray J.G., Laskin C.A. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta. 20:1999;519-529.
12. James S.J., Pogribna M., Pogribny I.I., Melnyk S., Hine R.J., Gibson J.B., Yi P., Tafoya D.L., Swenson D.H., Wilson V.L., Gaylor D.W. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down Syndrome. Am. J. Clin. Nutr. 70:1999;495-501.
13. Hobbs C.A., Sherman S.L., Yi P., Hopkins S.E., Torfs C.P., Hine R.J., Pogribna M., Rozen R., James S.J. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am. J. Hum. Genet. 67:2000;623-630.
14. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64:1998;169-172.
15. van der Put N.M.Y., Gabreels F., Stevens E.M.B., Smeitink J.A.M., Trijbels F.J.M., Eskes T.K.A.B., van den Heuvel L.P., Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects. Am. J. Hum. Genet. 62:1998;1044-1051.
16. Leclerc D., Campeau E., Goyette P., Adjalla C.E., Christensen B., Ross M., Eydoux P., Rosenblatt D.S., Rozen R., Gravel R.A. Human methionine synthase:cDNA cloning, chromosomal localization, and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum. Mol. Genet. 5:1996;1867-1874.
17. Banerjee R. Molecular biology of methionine synthase: interrelationships with homocysteine and vascular disease. Robinson K. Homocysteine and vascular disease. 2000;291-311 Kluwer Academic Publishers, Dordrecht, The Netherlands.
18. 12) increases risk for spina bifida. Mol. Genet. Metab. 67:1999;317-323.
19. Brown C.A., McKinney K.Q., Kaufman J.S., Gravel R.A., Rozen R. A common polymorphism in methionine synthase reductase increases risk for premature coronary artery disease. J. Cardiovasc. Risk. 7:2000;197-200.
20. Sunden S.L., Renduchintala M.S., Park E.I., Miklasz S.D., Garrow T.A. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch. Biochem. Biophys. 345:1997;171-174.
21. Rao P.V., Garrow T.W., Garland J.F., Millian N.S., Zigler J.S. Betaine-homocysteine methyltransferase is a developmentally regulated enzyme crystallin in rhesus monkey lens. J. Biol. Chem. 273:1998;30669-30674.
22. Finkelstein J.D., Martin J.J. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J. Biol. Chem. 259:1984;9508-9513.
23. Park E.I., Garrow T.A. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J. Biol. Chem. 274:1999;7816-7824.
24. Kang S.-S. Treatment of hyperhomocysteinemia: physiological basis. J. Nutr. 126:1996;1273S-1275.
25. Garrow T.A. Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J. Biol. Chem. 271:1996;22831-22838.
26. Glavac D., Dean M. Optimization of the single strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum. Mutat. 2:1993;404-414.
27. Millian N.S., Garrow T.A. Human betaine-homocysteine methyltransferase is a zinc metalloenzyme. Arch. Biochem. Biophys. 356:1998;93-98.
28. Garrow T.A. Betaine-dependent remethylation. Carmel R., Jacobsen D.W. Homocysteine in Health and Disease. 2001;145-152 Cambridge University Press, Cambridge, UK.
29. Sowden M.P., Collins H.L., Smith H.C., Garrow T.A., Sparks J.D., Sparks C.E. Apolipoprotein B mRNA and lipoprotein secretion are increased in McArdle RH-7777 cells by expression of betaine-homocysteine S-methyltransferase. Biochem. J. 341:1999;639-645.
30. Heil SG, Lievers KJA, Boers GH, Verhoef P, den Heijer M, Trijbels FJM, Blom HJ. Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. Mol Genet Metab 2000;71:511-19.
31. Morin I, Platt R, Weisberg I, Sabbaghian N, Wu Q, Garrow TA, Rozen R. A common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet, in press.